BFEC
PRPH

Benjamin F. Edwards & Company’s ProPhase Labs PRPH Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50
Closed -$6K – 1893
2022
Q3 		$6K Hold
50
– – ﹤0.01% 1525
2022
Q2 		$6K Buy
+50
New +$4.39K ﹤0.01% 1500

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return

Benjamin F. Edwards & Company's PRPH Position: Q4 2022 in Review

Benjamin F. Edwards & Company sold out of ProPhase Labs (PRPH) in Q4 2022, closing a stake of 50 shares — an estimated $6K sold.

Benjamin F. Edwards & Company first reported a position in PRPH in Q2 2022 and held it in 2 quarters. The position peaked at $6K in Q3 2022. 50 funds tracked by Wall St. Rank hold PRPH as of Q4 2022.

  • Benjamin F. Edwards & Company reported no remaining ProPhase Labs position as of Q4 2022 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 50 ProPhase Labs shares in Q4 2022, an estimated $6K.
  • Benjamin F. Edwards & Company first reported a position in ProPhase Labs in Q2 2022 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's ProPhase Labs position peaked at $6K in Q3 2022.
  • 50 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2022.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2022, filed 7 Feb 2023.